"Wall Street analysts are bullish on dividend stocks, highlighting their ability to provide steady income and mitigate market volatility, especially during downturns."
"Pfizer has a strong oncology pipeline with 108 potential drugs, which could continue to drive future revenue and growth, beyond its COVID-19 vaccine successes."
High-yield dividend stocks are increasingly favored as a strategy to combat market volatility. Analysts emphasize companies like Pfizer, which, despite challenges post-pandemic, boast a promising oncology drug pipeline and a solid dividend of around 7.3%. Pfizer has consistently increased dividends for 16 years, and predictions suggest yields could rise significantly. With the potential for ongoing revenue generation from the drug pipeline, analysts maintain a positive outlook, making dividend stocks an attractive option for investors looking to increase income and reduce risk in their portfolios.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]